Anti-integrin therapy for inflammatory bowel disease
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Gastroenterology,General Medicine
Reference55 articles.
1. Molecular pathways controlling barrier function in IBD
2. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
3. Immunopathogenesis of IBD: current state of the art
4. Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease
5. Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review;International Immunopharmacology;2024-12
2. Mucosal Immunity and Trained Innate Immunity of the Gut;Gastroenterology Insights;2024-08-02
3. Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients;Bioengineering;2024-07-12
4. The integrin receptor beta7 subunit mediates airway remodeling and hyperresponsiveness in allergen exposed mice;Respiratory Research;2024-07-12
5. Gut-tropic T cells and extra-intestinal autoimmune diseases;Autoimmunity Reviews;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3